Claire Mazumdar, the Chief Executive Officer of $BCAX, sold 11,445 shares of the company on 10-13-2025 for an estimated $216,545. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.6% of their shares of this class of stock. Following this trade, they now own 309,892 shares of this class of $BCAX stock.
$BCAX Insider Trading Activity
$BCAX insiders have traded $BCAX stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $BCAX stock by insiders over the last 6 months:
- RYAN COHLHEPP (President and COO) has made 0 purchases and 4 sales selling 50,500 shares for an estimated $911,841.
- LARA MEISNER (Chief Legal Officer) has made 0 purchases and 3 sales selling 65,465 shares for an estimated $845,624.
- IVAN HYEP (Chief Financial Officer) has made 0 purchases and 4 sales selling 36,800 shares for an estimated $670,129.
- CLAIRE MAZUMDAR (Chief Executive Officer) has made 0 purchases and 2 sales selling 24,734 shares for an estimated $466,936.
- DAVID RABEN (Chief Medical Officer) sold 22,000 shares for an estimated $405,900
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BCAX Analyst Ratings
Wall Street analysts have issued reports on $BCAX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 08/22/2025
- Piper Sandler issued a "Overweight" rating on 08/19/2025
To track analyst ratings and price targets for $BCAX, check out Quiver Quantitative's $BCAX forecast page.
$BCAX Price Targets
Multiple analysts have issued price targets for $BCAX recently. We have seen 3 analysts offer price targets for $BCAX in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $40.0 on 08/22/2025
- Kelsey Goodwin from Piper Sandler set a target price of $36.0 on 08/19/2025
- Eva Fortea Verdejo from Wells Fargo set a target price of $8.0 on 05/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
